Metp Holdings Llc - Net Worth and Insider Trading

Metp Holdings Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Metp Holdings Llc owns 1 companies in total, including Petros Pharmaceuticals Inc (PTPI) .

Click here to see the complete history of Metp Holdings Llc’s form 4 insider trades.

Insider Ownership Summary of Metp Holdings Llc

Ticker Comapny Transaction Date Type of Owner
PTPI Petros Pharmaceuticals Inc 2021-11-29 10 percent owner

Metp Holdings Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Metp Holdings Llc Ownership Network

Ownership Network List of Metp Holdings Llc

No Data

Ownership Network Relation of Metp Holdings Llc


Metp Holdings Llc Owned Company Details

What does Petros Pharmaceuticals Inc do?

Who are the key executives at Petros Pharmaceuticals Inc?

Metp Holdings Llc is the 10 percent owner of Petros Pharmaceuticals Inc. Other key executives at Petros Pharmaceuticals Inc include director & 10 percent owner John D Shulman , 10 percent owner Jcp Iii Sm Aiv, L.p. , and 10 percent owner Juggernaut Partners Iii Gp, L.p. .

Petros Pharmaceuticals Inc (PTPI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Petros Pharmaceuticals Inc (PTPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Petros Pharmaceuticals Inc (PTPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Petros Pharmaceuticals Inc (PTPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Petros Pharmaceuticals Inc Insider Transactions

No Available Data

Metp Holdings Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Metp Holdings Llc. You might contact Metp Holdings Llc via mailing address: 5301 Wisconsin Ave Nw, Suite 570, Washington Dc 20015.

Discussions on Metp Holdings Llc

No discussions yet.